Xueshuai Wan

1.7k total citations
50 papers, 1.1k citations indexed

About

Xueshuai Wan is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xueshuai Wan has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Xueshuai Wan's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Xueshuai Wan is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Xueshuai Wan collaborates with scholars based in China, United States and Germany. Xueshuai Wan's co-authors include Haitao Zhao, Xiaobo Yang, Anqiang Wang, Jianzhen Lin, Xinting Sang, Haohai Zhang, Junyu Long, Liangcai Wu, Ruoyu Miao and Yi Bai and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Xueshuai Wan

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueshuai Wan China 19 421 365 356 280 266 50 1.1k
Tsu‐Yao Cheng Taiwan 20 775 1.8× 301 0.8× 365 1.0× 284 1.0× 237 0.9× 42 1.4k
Yong Jiang China 21 585 1.4× 460 1.3× 221 0.6× 324 1.2× 185 0.7× 71 1.3k
Alexandra Pohl United States 15 332 0.8× 196 0.5× 539 1.5× 208 0.7× 243 0.9× 20 1.1k
Massimiliano Salati Italy 13 351 0.8× 313 0.9× 398 1.1× 166 0.6× 212 0.8× 58 945
Anand S. Merchant United States 18 465 1.1× 149 0.4× 327 0.9× 200 0.7× 126 0.5× 24 1.0k
Jonathan M. Harnoss Germany 16 519 1.2× 270 0.7× 562 1.6× 347 1.2× 127 0.5× 34 1.3k
Zhifang Jia China 19 329 0.8× 179 0.5× 312 0.9× 207 0.7× 232 0.9× 57 953
Fuminori Sonohara Japan 17 378 0.9× 264 0.7× 448 1.3× 301 1.1× 227 0.9× 64 960
Yuichiro Yokoyama Japan 15 348 0.8× 152 0.4× 287 0.8× 250 0.9× 95 0.4× 89 937
Hongyu Zhang China 16 301 0.7× 213 0.6× 334 0.9× 100 0.4× 149 0.6× 42 842

Countries citing papers authored by Xueshuai Wan

Since Specialization
Citations

This map shows the geographic impact of Xueshuai Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueshuai Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueshuai Wan more than expected).

Fields of papers citing papers by Xueshuai Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueshuai Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueshuai Wan. The network helps show where Xueshuai Wan may publish in the future.

Co-authorship network of co-authors of Xueshuai Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xueshuai Wan. A scholar is included among the top collaborators of Xueshuai Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueshuai Wan. Xueshuai Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Xingcheng, Yali Xu, Xiaosong Wang, et al.. (2025). A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors. Scientific Data. 13(1). 31–31.
3.
Chen, Xiaokun, Y.F. Zhang, Xueshuai Wan, et al.. (2025). Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study. Journal of Hepatocellular Carcinoma. Volume 12. 2213–2224.
4.
5.
Wan, Xueshuai, Karin Wisskirchen, Xiaorui Wang, et al.. (2024). Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. Clinical and Molecular Hepatology. 30(4). 735–755. 16 indexed citations
6.
Xu, Gang, Bao Jin, Xueshuai Wan, et al.. (2024). Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study. World Journal of Surgical Oncology. 22(1). 263–263.
7.
8.
Ding, Peiwen, Xueshuai Wan, Gang Xu, et al.. (2023). Application and Progress of Cultured Models of Gallbladder Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 5 indexed citations
9.
10.
11.
Lin, Jianzhen, Junping Shi, Honglin Guo, et al.. (2019). Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clinical Cancer Research. 25(15). 4701–4711. 80 indexed citations
12.
Huang, Hanchun, Xueshuai Wan, Yi Bai, et al.. (2019). <p>Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma</p>. Cancer Management and Research. Volume 11. 5157–5162. 15 indexed citations
13.
Bai, Yi, Jianping Xiong, Weiyu Xu, et al.. (2018). Nomogram to predict overall survival after gallbladder cancer resection in China. World Journal of Gastroenterology. 24(45). 5167–5178. 30 indexed citations
14.
Long, Junyu, Jianzhen Lin, Anqiang Wang, et al.. (2017). PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. Journal of Hematology & Oncology. 10(1). 146–146. 84 indexed citations
15.
Wang, Yipeng, et al.. (2017). Protrusion of a rod into the spinal canal 10 years after segmental lumbar spine surgery. Medicine. 96(12). e6425–e6425.
16.
Wang, Anqiang, Shanshan Wang, Chengpei Zhu, et al.. (2016). Coffee and cancer risk: A meta-analysis of prospective observational studies. Scientific Reports. 6(1). 33711–33711. 67 indexed citations
17.
Yang, Zhen, Xueshuai Wan, Haohai Zhang, et al.. (2014). Evolution of the mir-181 microRNA family. Computers in Biology and Medicine. 52. 82–87. 27 indexed citations
18.
Wan, Xueshuai & Haitao Zhao. (2014). New avenues to treatment of liver cirrhosis. Science China Life Sciences. 57(10). 1049–1050. 2 indexed citations
19.
Yang, Zhen, Xiaobo Yang, Xueshuai Wan, et al.. (2014). A phylogenetic analysis of the ubiquitin superfamily based on sequence and structural information. Molecular Biology Reports. 41(9). 6083–6088. 3 indexed citations
20.
Wan, Xueshuai, Xiaobo Yang, Anqiang Wang, et al.. (2014). Clinicopathological Features of Gallbladder Papillary Adenocarcinoma. Medicine. 93(27). e131–e131. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsu‐Yao Cheng Breakdown of academic impact, for papers by Yong Jiang Breakdown of academic impact, for papers by Alexandra Pohl Breakdown of academic impact, for papers by Massimiliano Salati Breakdown of academic impact, for papers by Anand S. Merchant Breakdown of academic impact, for papers by Jonathan M. Harnoss Breakdown of academic impact, for papers by Zhifang Jia Breakdown of academic impact, for papers by Fuminori Sonohara Breakdown of academic impact, for papers by Yuichiro Yokoyama Breakdown of academic impact, for papers by Hongyu Zhang
Rankless by CCL
2026